One Health Antimicrobial Resistance (OHAMR): First Call for Proposals

The European Partnership on One Health Antimicrobial Resistance (EUP OHAMR) is launching its first transnational call within the focus area of providing innovative and cost-effective treatment options. Antimicrobial resistance (AMR) is a global health challenge that affects human and animal health, food security and the environment. The programme brings together 53 organisations from 30 countries in the EU and beyond to address AMR challenges across sectors and One Health domains. Swiss-based researchers can participate on equal terms with teams from EU member states and other associated countries. The first call covers three main topics: (1) Identify and develop new combination treatments using existing or innovative antimicrobials or antimicrobial with adjunctive treatments to extend drug efficacy and combat resistance; (2) Develop tools and methods to improve adherence to treatment protocols; (3) Assess the impact of antimicrobials for veterinary and agricultural use on the risk of AMR transmission to humans and the environment to inform policies on the restriction of some antimicrobials for human use. The call follows a two-step submission process with pre-proposals due February 2, 2026 and full proposals due June 17, 2026. Applications must be submitted at both the central level (via the Joint Call Secretariat) and at the national level (Swiss partners must submit through SNSF's mySNF platform). Swiss partners must meet the SNSF's Project funding eligibility criteria to receive funding.